tradingkey.logo

Stevanato Group SpA

STVN
View Detailed Chart
15.500USD
+1.350+9.54%
Close 02/06, 16:00ETQuotes delayed by 15 min
4.23BMarket Cap
35.26P/E TTM

Stevanato Group SpA

15.500
+1.350+9.54%
Intraday
1m
30m
1h
D
W
M
D

Today

+9.54%

5 Days

-0.51%

1 Month

-28.21%

6 Months

-35.55%

Year to Date

-22.96%

1 Year

-31.05%

View Detailed Chart

TradingKey Stock Score of Stevanato Group SpA

Currency: USD Updated: 2026-02-06

Key Insights

Stevanato Group SpA's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 58 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 28.99.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Stevanato Group SpA's Score

Industry at a Glance

Industry Ranking
58 / 205
Overall Ranking
162 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Stevanato Group SpA Highlights

StrengthsRisks
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 12.27%.
Undervalued
The company’s latest PE is 35.26, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 53.34M shares, decreasing 22.52% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 945.00 shares of this stock.

Analyst Rating

Based on 11 analysts
Buy
Current Rating
28.993
Target Price
+104.90%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Stevanato Group SpA News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Stevanato Group SpA Info

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Ticker SymbolSTVN
CompanyStevanato Group SpA
CEOStevanato (Franco)
Websitehttps://www.stevanatogroup.com/
KeyAI